▶ 調査レポート

世界のがんにおける人工知能(AI)市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Artificial Intelligence (AI) in Cancer Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のがんにおける人工知能(AI)市場規模・現状・予測(2021年-2027年) / Global Artificial Intelligence (AI) in Cancer Market Size, Status and Forecast 2021-2027 / QFJ1-3857資料のイメージです。• レポートコード:QFJ1-3857
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、123ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、がんにおける人工知能(AI)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(外科、放射線療法、化学療法、免疫療法、光線療法、遺伝子治療、ソノダイナミック療法)、用途別市場規模(診断、治療、予後、健康管理、研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・がんにおける人工知能(AI)の市場動向
・企業の競争状況、市場シェア
・がんにおける人工知能(AI)の種類別市場規模と予測2016-2027(外科、放射線療法、化学療法、免疫療法、光線療法、遺伝子治療、ソノダイナミック療法)
・がんにおける人工知能(AI)の用途別市場規模と予測2016-2027(診断、治療、予後、健康管理、研究所)
・がんにおける人工知能(AI)の北米市場規模2016-2027(アメリカ、カナダ)
・がんにおける人工知能(AI)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・がんにおける人工知能(AI)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・がんにおける人工知能(AI)の中南米市場規模2016-2027(メキシコ、ブラジル)
・がんにおける人工知能(AI)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(IBM、Microsoft、NVIDIA、Intel、GE Healthcare、Johnson & Johnson、Cancer Center.ai、Digital Reasoning、Varian Medical Systems、Niramai、Densitas、MammoScreen、MVision AI、Volpara、LungLifeAI)
・結論

Integration of AI technology in cancer care could improve the accuracy and speed of diagnosis, aid clinical decision-making, and lead to better health outcomes. AI-guided clinical care has the potential to play an important role in reducing health disparities, particularly in low-resource settings.

Market Analysis and Insights: Global Artificial Intelligence (AI) in Cancer Market
The global Artificial Intelligence (AI) in Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Artificial Intelligence (AI) in Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Artificial Intelligence (AI) in Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Artificial Intelligence (AI) in Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Artificial Intelligence (AI) in Cancer market.

Global Artificial Intelligence (AI) in Cancer Scope and Market Size
Artificial Intelligence (AI) in Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence (AI) in Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Phototherapy
Gene Therapy
Sonodynamic Therapy

Segment by Application
Diagnosis
Therapy
Prognosis
Health Management
Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
IBM
Microsoft
NVIDIA
Intel
GE Healthcare
Johnson & Johnson
Cancer Center.ai
Digital Reasoning
Varian Medical Systems
Niramai
Densitas
MammoScreen
MVision AI
Volpara
LungLifeAI

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Surgery
1.2.3 Radiotherapy
1.2.4 Chemotherapy
1.2.5 Immunotherapy
1.2.6 Phototherapy
1.2.7 Gene Therapy
1.2.8 Sonodynamic Therapy
1.3 Market by Application
1.3.1 Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnosis
1.3.3 Therapy
1.3.4 Prognosis
1.3.5 Health Management
1.3.6 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Artificial Intelligence (AI) in Cancer Market Perspective (2016-2027)
2.2 Artificial Intelligence (AI) in Cancer Growth Trends by Regions
2.2.1 Artificial Intelligence (AI) in Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Artificial Intelligence (AI) in Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Artificial Intelligence (AI) in Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Artificial Intelligence (AI) in Cancer Industry Dynamic
2.3.1 Artificial Intelligence (AI) in Cancer Market Trends
2.3.2 Artificial Intelligence (AI) in Cancer Market Drivers
2.3.3 Artificial Intelligence (AI) in Cancer Market Challenges
2.3.4 Artificial Intelligence (AI) in Cancer Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue
3.1.1 Global Top Artificial Intelligence (AI) in Cancer Players by Revenue (2016-2021)
3.1.2 Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Artificial Intelligence (AI) in Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence (AI) in Cancer Revenue
3.4 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio
3.4.1 Global Artificial Intelligence (AI) in Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence (AI) in Cancer Revenue in 2020
3.5 Artificial Intelligence (AI) in Cancer Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence (AI) in Cancer Product Solution and Service
3.7 Date of Enter into Artificial Intelligence (AI) in Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Artificial Intelligence (AI) in Cancer Breakdown Data by Type
4.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Type (2016-2021)
4.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2022-2027)

5 Artificial Intelligence (AI) in Cancer Breakdown Data by Application
5.1 Global Artificial Intelligence (AI) in Cancer Historic Market Size by Application (2016-2021)
5.2 Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Artificial Intelligence (AI) in Cancer Market Size (2016-2027)
6.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type
6.2.1 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021)
6.2.2 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027)
6.2.3 North America Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2027)
6.3 North America Artificial Intelligence (AI) in Cancer Market Size by Application
6.3.1 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021)
6.3.2 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027)
6.3.3 North America Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2027)
6.4 North America Artificial Intelligence (AI) in Cancer Market Size by Country
6.4.1 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021)
6.4.2 North America Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Artificial Intelligence (AI) in Cancer Market Size (2016-2027)
7.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type
7.2.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021)
7.2.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027)
7.2.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2027)
7.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application
7.3.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021)
7.3.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027)
7.3.3 Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2027)
7.4 Europe Artificial Intelligence (AI) in Cancer Market Size by Country
7.4.1 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021)
7.4.2 Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size (2016-2027)
8.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Type
8.2.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Application
8.3.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region
8.4.1 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Artificial Intelligence (AI) in Cancer Market Size (2016-2027)
9.2 Latin America Artificial Intelligence (AI) in Cancer Market Size by Type
9.2.1 Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2027)
9.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Application
9.3.1 Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2027)
9.4 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country
9.4.1 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size (2016-2027)
10.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type
10.2.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application
10.3.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country
10.4.1 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 IBM
11.1.1 IBM Company Details
11.1.2 IBM Business Overview
11.1.3 IBM Artificial Intelligence (AI) in Cancer Introduction
11.1.4 IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.1.5 IBM Recent Development
11.2 Microsoft
11.2.1 Microsoft Company Details
11.2.2 Microsoft Business Overview
11.2.3 Microsoft Artificial Intelligence (AI) in Cancer Introduction
11.2.4 Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.2.5 Microsoft Recent Development
11.3 NVIDIA
11.3.1 NVIDIA Company Details
11.3.2 NVIDIA Business Overview
11.3.3 NVIDIA Artificial Intelligence (AI) in Cancer Introduction
11.3.4 NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.3.5 NVIDIA Recent Development
11.4 Intel
11.4.1 Intel Company Details
11.4.2 Intel Business Overview
11.4.3 Intel Artificial Intelligence (AI) in Cancer Introduction
11.4.4 Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.4.5 Intel Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Artificial Intelligence (AI) in Cancer Introduction
11.5.4 GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.5.5 GE Healthcare Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Artificial Intelligence (AI) in Cancer Introduction
11.6.4 Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.6.5 Johnson & Johnson Recent Development
11.7 Cancer Center.ai
11.7.1 Cancer Center.ai Company Details
11.7.2 Cancer Center.ai Business Overview
11.7.3 Cancer Center.ai Artificial Intelligence (AI) in Cancer Introduction
11.7.4 Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.7.5 Cancer Center.ai Recent Development
11.8 Digital Reasoning
11.8.1 Digital Reasoning Company Details
11.8.2 Digital Reasoning Business Overview
11.8.3 Digital Reasoning Artificial Intelligence (AI) in Cancer Introduction
11.8.4 Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.8.5 Digital Reasoning Recent Development
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Details
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Artificial Intelligence (AI) in Cancer Introduction
11.9.4 Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.9.5 Varian Medical Systems Recent Development
11.10 Niramai
11.10.1 Niramai Company Details
11.10.2 Niramai Business Overview
11.10.3 Niramai Artificial Intelligence (AI) in Cancer Introduction
11.10.4 Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.10.5 Niramai Recent Development
11.11 Densitas
11.11.1 Densitas Company Details
11.11.2 Densitas Business Overview
11.11.3 Densitas Artificial Intelligence (AI) in Cancer Introduction
11.11.4 Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.11.5 Densitas Recent Development
11.12 MammoScreen
11.12.1 MammoScreen Company Details
11.12.2 MammoScreen Business Overview
11.12.3 MammoScreen Artificial Intelligence (AI) in Cancer Introduction
11.12.4 MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.12.5 MammoScreen Recent Development
11.13 MVision AI
11.13.1 MVision AI Company Details
11.13.2 MVision AI Business Overview
11.13.3 MVision AI Artificial Intelligence (AI) in Cancer Introduction
11.13.4 MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.13.5 MVision AI Recent Development
11.14 Volpara
11.14.1 Volpara Company Details
11.14.2 Volpara Business Overview
11.14.3 Volpara Artificial Intelligence (AI) in Cancer Introduction
11.14.4 Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.14.5 Volpara Recent Development
11.15 LungLifeAI
11.15.1 LungLifeAI Company Details
11.15.2 LungLifeAI Business Overview
11.15.3 LungLifeAI Artificial Intelligence (AI) in Cancer Introduction
11.15.4 LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021)
11.15.5 LungLifeAI Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Artificial Intelligence (AI) in Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Surgery
Table 3. Key Players of Radiotherapy
Table 4. Key Players of Chemotherapy
Table 5. Key Players of Immunotherapy
Table 6. Key Players of Phototherapy
Table 7. Key Players of Gene Therapy
Table 8. Key Players of Sonodynamic Therapy
Table 9. Global Artificial Intelligence (AI) in Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Artificial Intelligence (AI) in Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Artificial Intelligence (AI) in Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Artificial Intelligence (AI) in Cancer Market Share by Regions (2016-2021)
Table 13. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Artificial Intelligence (AI) in Cancer Market Share by Regions (2022-2027)
Table 15. Artificial Intelligence (AI) in Cancer Market Trends
Table 16. Artificial Intelligence (AI) in Cancer Market Drivers
Table 17. Artificial Intelligence (AI) in Cancer Market Challenges
Table 18. Artificial Intelligence (AI) in Cancer Market Restraints
Table 19. Global Artificial Intelligence (AI) in Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Artificial Intelligence (AI) in Cancer Market Share by Players (2016-2021)
Table 21. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2020)
Table 22. Ranking of Global Top Artificial Intelligence (AI) in Cancer Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Artificial Intelligence (AI) in Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Artificial Intelligence (AI) in Cancer Product Solution and Service
Table 26. Date of Enter into Artificial Intelligence (AI) in Cancer Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2016-2021)
Table 30. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Artificial Intelligence (AI) in Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2016-2021)
Table 34. Global Artificial Intelligence (AI) in Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 66. IBM Company Details
Table 67. IBM Business Overview
Table 68. IBM Artificial Intelligence (AI) in Cancer Product
Table 69. IBM Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 70. IBM Recent Development
Table 71. Microsoft Company Details
Table 72. Microsoft Business Overview
Table 73. Microsoft Artificial Intelligence (AI) in Cancer Product
Table 74. Microsoft Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 75. Microsoft Recent Development
Table 76. NVIDIA Company Details
Table 77. NVIDIA Business Overview
Table 78. NVIDIA Artificial Intelligence (AI) in Cancer Product
Table 79. NVIDIA Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 80. NVIDIA Recent Development
Table 81. Intel Company Details
Table 82. Intel Business Overview
Table 83. Intel Artificial Intelligence (AI) in Cancer Product
Table 84. Intel Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 85. Intel Recent Development
Table 86. GE Healthcare Company Details
Table 87. GE Healthcare Business Overview
Table 88. GE Healthcare Artificial Intelligence (AI) in Cancer Product
Table 89. GE Healthcare Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 90. GE Healthcare Recent Development
Table 91. Johnson & Johnson Company Details
Table 92. Johnson & Johnson Business Overview
Table 93. Johnson & Johnson Artificial Intelligence (AI) in Cancer Product
Table 94. Johnson & Johnson Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 95. Johnson & Johnson Recent Development
Table 96. Cancer Center.ai Company Details
Table 97. Cancer Center.ai Business Overview
Table 98. Cancer Center.ai Artificial Intelligence (AI) in Cancer Product
Table 99. Cancer Center.ai Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 100. Cancer Center.ai Recent Development
Table 101. Digital Reasoning Company Details
Table 102. Digital Reasoning Business Overview
Table 103. Digital Reasoning Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 104. Digital Reasoning Recent Development
Table 105. Varian Medical Systems Company Details
Table 106. Varian Medical Systems Business Overview
Table 107. Varian Medical Systems Artificial Intelligence (AI) in Cancer Product
Table 108. Varian Medical Systems Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 109. Varian Medical Systems Recent Development
Table 110. Niramai Company Details
Table 111. Niramai Business Overview
Table 112. Niramai Artificial Intelligence (AI) in Cancer Product
Table 113. Niramai Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 114. Niramai Recent Development
Table 115. Densitas Company Details
Table 116. Densitas Business Overview
Table 117. Densitas Artificial Intelligence (AI) in Cancer Product
Table 118. Densitas Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 119. Densitas Recent Development
Table 120. MammoScreen Company Details
Table 121. MammoScreen Business Overview
Table 122. MammoScreen Artificial Intelligence (AI) in Cancer Product
Table 123. MammoScreen Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 124. MammoScreen Recent Development
Table 125. MVision AI Company Details
Table 126. MVision AI Business Overview
Table 127. MVision AI Artificial Intelligence (AI) in Cancer Product
Table 128. MVision AI Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 129. MVision AI Recent Development
Table 130. Volpara Company Details
Table 131. Volpara Business Overview
Table 132. Volpara Artificial Intelligence (AI) in Cancer Product
Table 133. Volpara Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 134. Volpara Recent Development
Table 135. LungLifeAI Company Details
Table 136. LungLifeAI Business Overview
Table 137. LungLifeAI Artificial Intelligence (AI) in Cancer Product
Table 138. LungLifeAI Revenue in Artificial Intelligence (AI) in Cancer Business (2016-2021) & (US$ Million)
Table 139. LungLifeAI Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artificial Intelligence (AI) in Cancer Market Share by Type: 2020 VS 2027
Figure 2. Surgery Features
Figure 3. Radiotherapy Features
Figure 4. Chemotherapy Features
Figure 5. Immunotherapy Features
Figure 6. Phototherapy Features
Figure 7. Gene Therapy Features
Figure 8. Sonodynamic Therapy Features
Figure 9. Global Artificial Intelligence (AI) in Cancer Market Share by Application: 2020 VS 2027
Figure 10. Diagnosis Case Studies
Figure 11. Therapy Case Studies
Figure 12. Prognosis Case Studies
Figure 13. Health Management Case Studies
Figure 14. Research Case Studies
Figure 15. Artificial Intelligence (AI) in Cancer Report Years Considered
Figure 16. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 17. Global Artificial Intelligence (AI) in Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 18. Global Artificial Intelligence (AI) in Cancer Market Share by Regions: 2020 VS 2027
Figure 19. Global Artificial Intelligence (AI) in Cancer Market Share by Regions (2022-2027)
Figure 20. Global Artificial Intelligence (AI) in Cancer Market Share by Players in 2020
Figure 21. Global Top Artificial Intelligence (AI) in Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Artificial Intelligence (AI) in Cancer as of 2020
Figure 22. The Top 10 and 5 Players Market Share by Artificial Intelligence (AI) in Cancer Revenue in 2020
Figure 23. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2016-2021)
Figure 24. Global Artificial Intelligence (AI) in Cancer Revenue Market Share by Type (2022-2027)
Figure 25. North America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. North America Artificial Intelligence (AI) in Cancer Market Share by Type (2016-2027)
Figure 27. North America Artificial Intelligence (AI) in Cancer Market Share by Application (2016-2027)
Figure 28. North America Artificial Intelligence (AI) in Cancer Market Share by Country (2016-2027)
Figure 29. United States Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Canada Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Europe Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Artificial Intelligence (AI) in Cancer Market Share by Type (2016-2027)
Figure 33. Europe Artificial Intelligence (AI) in Cancer Market Share by Application (2016-2027)
Figure 34. Europe Artificial Intelligence (AI) in Cancer Market Share by Country (2016-2027)
Figure 35. Germany Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. France Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. U.K. Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Italy Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Russia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Nordic Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Share by Type (2016-2027)
Figure 43. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Share by Application (2016-2027)
Figure 44. Asia-Pacific Artificial Intelligence (AI) in Cancer Market Share by Region (2016-2027)
Figure 45. China Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Japan Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. South Korea Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Southeast Asia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. India Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Australia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Latin America Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Artificial Intelligence (AI) in Cancer Market Share by Type (2016-2027)
Figure 53. Latin America Artificial Intelligence (AI) in Cancer Market Share by Application (2016-2027)
Figure 54. Latin America Artificial Intelligence (AI) in Cancer Market Share by Country (2016-2027)
Figure 55. Mexico Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Brazil Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Share by Type (2016-2027)
Figure 59. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Share by Application (2016-2027)
Figure 60. Middle East & Africa Artificial Intelligence (AI) in Cancer Market Share by Country (2016-2027)
Figure 61. Turkey Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Saudi Arabia Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. UAE Artificial Intelligence (AI) in Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. IBM Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 65. Microsoft Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 66. NVIDIA Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 67. Intel Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 68. GE Healthcare Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 69. Johnson & Johnson Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 70. Cancer Center.ai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 71. Digital Reasoning Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 72. Varian Medical Systems Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 73. Niramai Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 74. Densitas Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 75. MammoScreen Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 76. MVision AI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 77. Volpara Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 78. LungLifeAI Revenue Growth Rate in Artificial Intelligence (AI) in Cancer Business (2016-2021)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed